Bluejay Diagnostics, Inc. (BJDX) stock
BJDXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$2.15−0.14 (-5.90%)
Close on Nov 17, 2026Market cap $9.63MP/E –Yield –
Bluejay Diagnostics cash
Cash and short-term investments held at the end of each period.
Bluejay Diagnostics's cash was $9.60M at Jun 30, 2026. For fiscal 2025 it was $5.16M, up 20.1% from the year before. The highest annual figure on record is $19.05M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.16M | +20.1% |
| FY2024 | Dec 31, 2024 | $4.30M | +94.8% |
| FY2023 | Dec 31, 2023 | $2.21M | -78.2% |
| FY2022 | Dec 31, 2022 | $10.11M | -46.9% |
| FY2021 | Dec 31, 2021 | $19.05M | +1987.7% |
| FY2020 | Dec 31, 2020 | $912.36K | +850.3% |
| FY2019 | Dec 31, 2019 | $96.01K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $9.60M | +116.0% |
| Q1 FY2026 | Mar 31, 2026 | $3.68M | +18.2% |
| Q4 FY2025 | Dec 31, 2025 | $5.16M | +20.1% |
| Q3 FY2025 | Sep 30, 2025 | $3.08M | -46.4% |
| Q2 FY2025 | Jun 30, 2025 | $4.44M | -44.9% |
| Q1 FY2025 | Mar 31, 2025 | $3.12M | +17.1% |
| Q4 FY2024 | Dec 31, 2024 | $4.30M | +94.8% |
| Q3 FY2024 | Sep 30, 2024 | $5.76M | +13.4% |
| Q2 FY2024 | Jun 30, 2024 | $8.06M | +58.0% |
| Q1 FY2024 | Mar 31, 2024 | $2.66M | -60.8% |
| Q4 FY2023 | Dec 31, 2023 | $2.21M | -78.2% |
| Q3 FY2023 | Sep 30, 2023 | $5.08M | -61.8% |
| Q2 FY2023 | Jun 30, 2023 | $5.10M | -66.8% |
| Q1 FY2023 | Mar 31, 2023 | $6.78M | -60.4% |
| Q4 FY2022 | Dec 31, 2022 | $10.11M | -46.9% |
| Q3 FY2022 | Sep 30, 2022 | $13.29M | +470.3% |
| Q2 FY2022 | Jun 30, 2022 | $15.34M | +1581.6% |
| Q1 FY2022 | Mar 31, 2022 | $17.12M | +17735.6% |
| Q4 FY2021 | Dec 31, 2021 | $19.05M | – |
| Q3 FY2021 | Sep 30, 2021 | $2.33M | – |
| Q4 FY2020 | Dec 31, 2020 | $912.36K | – |
| Q4 FY2019 | Dec 31, 2019 | $96.01K | – |
See a number that looks wrong?